NCT01257958

Vitamin D Pilot Study in Patients With Multiple Sclerosis

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: —
• Sponsor: University of Wisconsin, Madison · Academic / Other
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.

Conditions

• Relapsing Remitting Multiple Sclerosis

Interventions

Type	Name	Description
DRUG	19 nor vitamin d

Timeline

• Start date: 1998-02-01
• Primary completion: 2000-02-01
• Completion: 2000-06-01
• First posted: 2010-12-10
• Last updated: 2015-10-05

Locations

1 site across 1 country: United States